Drug General Information
Drug ID	D03FFY
Former ID	DCL000466
Drug Name	AZD3355
Drug Type	Small molecular drug
Indication	Gastroesophageal reflux disease [ICD9: 140-229, 530; ICD10:K21]		Discontinued in Phase 2	[542680], [547426]
Company	AstraZeneca
Structure		Download 2D MOL 3D MOL
Formula	C3H9FNO2P
InChI	InChI=1S/C3H9FNO2P/c4-3(1-5)2-8(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m1/s1
InChIKey	LJNUIEQATDYXJH-GSVOUGTGSA-N
PubChem Compound ID	16686147
PubChem Substance ID	198937103
Target and Pathway
Target(s)	GABA B receptor	Target Info	Modulator
References
Ref 542680	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7705).
Ref 547426	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016139)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.